Skip to content
DataLookout
Menu

NCT07193017

The Effect of BIPAP on Diaphragmatic Function

StatusActive, Not Recruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved 5 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 19 words Show 5 more changesShow less
    • Primary endpoints: details revised at 1 of 11 entries
    • Trial status changed: Not Yet Recruiting → Active, Not Recruiting
    • Primary completion pushed from Oct 15, 2026 to Mar 15, 2027
    • Secondary endpoints: details revised at 1 of 2 entries
    • Site contact updated
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

One-Year Survival
Timeframe: at baseline and after 12 months
Number of Hospital Admissions within 12 Months
Timeframe: at baseline and after 12 months
Maximum Inspiratory Pressure (MIP)
Timeframe: Baseline, after 6 weeks of BiPAP usage, and after one year
Maximum Expiratory Pressure (MEP)
Timeframe: At baseline, after 6 weeks of BiPAP usage, and after one year.
Forced Vital Capacity (FVC)
Timeframe: Baseline, after 6 weeks of BiPAP usage, and after one year.
Forced Expiratory Volume in 1 Second (FEV₁)
Timeframe: Baseline, after 6 weeks of BiPAP usage, and after one year.
FEV₁/FVC Ratio
Timeframe: Baseline, after 6 weeks of BiPAP usage, and after one year.
Cough Strength (Peak Cough Flow, PCF)
Timeframe: Baseline, after 6 weeks of BiPAP usage, and after one year.
Diaphragm Thickness (B-mode Ultrasound)
Timeframe: Baseline, after 6 weeks of BiPAP usage, and after one year.
Diaphragm Excursion (M-mode Ultrasound)
Timeframe: Baseline, after 6 weeks of BiPAP usage, and after one year.
Diaphragmatic Tissue Velocity (Tissue Doppler Imaging)
Timeframe: Baseline, after 6 weeks of BiPAP usage, and after one year.

Secondary (2)

COPD Assessment Test (CAT) Score:
Dyspnea (mMRC Scale)

Arms and interventions

copd patients

Patients diagnosed with chronic obstructive pulmonary disease (COPD) who have been prescribed BiPAP therapy by a physician. Participants will undergo diaphragmatic function evaluations with ultrasound at baseline, after 6 weeks of BiPAP usage, and after one year.

Devices: BIPAP

Sites

1 site in 1 country

  • Demiroglu Bilim University, Department of Physiotherapy and RehabilitationIstanbul, Turkey (Türkiye)